Liraglutid 3 mg. Therapie von Adipositas: GLP-1-Rezeptoragonist als neue Therapieoption (Sponsor: Novo Nordisk Pharma GmbH)
-
Published:2016-04-28
Issue:01
Volume:10
Page:1-12
-
ISSN:2199-6997
-
Container-title:Thieme Drug Report
-
language:de
-
Short-container-title:TDR
Publisher
Georg Thieme Verlag KG
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献